Exploring 2016 Wmif Disruptive Dozen 12
Exploring 2016 Wmif Disruptive Dozen 12 reveals several interesting facts.
- 12
- Machine Learning and Computational Biology to Transform Cancer Care Introduction by: Daniel Haber, MD, PhD, Director, MGH ...
- Patient-Specific Research to Enable Efficient Drug Development Introduction by: Daniel Haber, MD, PhD, Director, MGH Cancer ...
- Cellular Immunotherapy Introduction by: Daniel Haber, MD, PhD, Director, MGH Cancer Center, Kurt J. Isselbacher/Peter D.
- Moderator: Katherine Andriole, PhD, Director of Research Strategy and Operations, MGH & BWH CCDS; Associate Professor, ...
In-Depth Information on 2016 Wmif Disruptive Dozen 12
Nanotechnology and Cancer Treatment Introduction by: Monica Bertagnolli, MD, Chief, Division of Surgical Oncology, BWH, ... Redefining Value in Cancer Care Introduction by: Daniel Haber, MD, PhD, Director, MGH Cancer Center, Kurt J. Isselbacher/Peter ... Moderators: Calum MacRae, MD, PhD, Chief of Cardiovascular Medicine, Brigham and Women's Hospital; Associate Professor of ... The Microbiome and Cancer Introduction by: Monica Bertagnolli, MD, Chief, Division of Surgical Oncology, BWH, Professor of ...
CRISPR: Genome Editing and Cancer Introduction by: Daniel Haber, MD, PhD, Director, MGH Cancer Center, Kurt J.
Stay tuned for more updates related to 2016 Wmif Disruptive Dozen 12.
